The Impact of COVID-19 is included in Peripheral Neuropathy Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Peripheral Neuropathy Trends and Forecast
The future of the global peripheral neuropathy market looks promising with opportunities in the hospital and clinic and ambulatory center markets. The global peripheral neuropathy market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are surge in geriatric and obese population and increasing occurence of diabetes.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Peripheral Neuropathy by Segment
The study includes a forecast for the global peripheral neuropathy by type, treatment, end use, and region.
Peripheral Neuropathy Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Diabetic Peripheral Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy
• Idiopathic Peripheral Neuropathy
• HIV/AIDS Associated Peripheral Neuropathy
Peripheral Neuropathy Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Pharmacological Therapies
• Non-Pharmacological Therapies
• Others
Peripheral Neuropathy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals and Clinics
• Ambulatory Centers
• Others
Peripheral Neuropathy Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Peripheral Neuropathy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies peripheral neuropathy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the peripheral neuropathy companies profiled in this report include-
• Abbott
• Bristol Myers Squibb
• Novartis
• Eli Lilly
• Pfizer
Peripheral Neuropathy Market Insights
Lucintel forecasts that pharmacological therapy will remain the larger segment over the forecast period as it is more effective and easy to use.
Within this market, hospital and clinic will remain the larger segment due to availability of different treatment methods along with presence of expertise in these facilities.
North America will remain the largest region over the forecast period due to high prevalence of diabetes patients and presence of healthcare infrastructure in the region.
Features of the Global Peripheral Neuropathy Market
Market Size Estimates: Peripheral neuropathy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Peripheral neuropathy market size by type, treatment, end use, and region in terms of value ($B).
Regional Analysis: Peripheral neuropathy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, treatment, end uses, and regions for the peripheral neuropathy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the peripheral neuropathy market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for peripheral neuropathy market?
Answer: The global peripheral neuropathy market is expected to grow with a CAGR of 7.0% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the peripheral neuropathy market?
Answer: The major drivers for this market are surge in geriatric and obese population and increasing occurence of diabetes.
Q3. What are the major segments for peripheral neuropathy market?
Answer: The future of the peripheral neuropathy market looks promising with opportunities in the hospital and clinic and ambulatory center markets.
Q4. Who are the key peripheral neuropathy market companies?
Answer: Some of the key peripheral neuropathy companies are as follows:
• Abbott
• Bristol Myers Squibb
• Novartis
• Eli Lilly
• Pfizer
Q5. Which peripheral neuropathy market segment will be the largest in future?
Answer: Lucintel forecasts that pharmacological therapy will remain the larger segment over the forecast period as it is more effective and easy to use.
Q6. In peripheral neuropathy market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes patients and presence of healthcare infrastructure in the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the peripheral neuropathy market by type (diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy, and HIV/AIDS associated peripheral neuropathy), treatment (pharmacological therapies, non-pharmacological therapies, and others), end use (hospitals and clinics, ambulatory centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Peripheral Neuropathy Market, Peripheral Neuropathy Market Size, Peripheral Neuropathy Market Growth, Peripheral Neuropathy Market Analysis, Peripheral Neuropathy Market Report, Peripheral Neuropathy Market Share, Peripheral Neuropathy Market Trends, Peripheral Neuropathy Market Forecast, Peripheral Neuropathy Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Peripheral Neuropathy Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Peripheral Neuropathy Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Peripheral Neuropathy Market by Type
3.3.1: Diabetic Peripheral Neuropathy
3.3.2: Chemotherapy-induced Peripheral Neuropathy
3.3.3: Idiopathic Peripheral Neuropathy
3.3.4: HIV/AIDS Associated Peripheral Neuropathy
3.4: Global Peripheral Neuropathy Market by Treatment
3.4.1: Pharmacological Therapies
3.4.2: Non-Pharmacological Therapies
3.4.3: Others
3.5: Global Peripheral Neuropathy Market by End Use
3.5.1: Hospitals and Clinics
3.5.2: Ambulatory Centers
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Peripheral Neuropathy Market by Region
4.2: North American Peripheral Neuropathy Market
4.2.1: North American Peripheral Neuropathy Market by Treatment: Pharmacological Therapies, Non-Pharmacological Therapies, and Others
4.2.2: North American Peripheral Neuropathy Market by End Use: Hospitals and Clinics, Ambulatory Centers, and Others
4.3: European Peripheral Neuropathy Market
4.3.1: European Peripheral Neuropathy Market by Treatment: Pharmacological Therapies, Non-Pharmacological Therapies, and Others
4.3.2: European Peripheral Neuropathy Market by End Use: Hospitals and Clinics, Ambulatory Centers, and Others
4.4: APAC Peripheral Neuropathy Market
4.4.1: APAC Peripheral Neuropathy Market by Treatment: Pharmacological Therapies, Non-Pharmacological Therapies, and Others
4.4.2: APAC Peripheral Neuropathy Market by End Use: Hospitals and Clinics, Ambulatory Centers, and Others
4.5: ROW Peripheral Neuropathy Market
4.5.1: ROW Peripheral Neuropathy Market by Treatment: Pharmacological Therapies, Non-Pharmacological Therapies, and Others
4.5.2: ROW Peripheral Neuropathy Market by End Use: Hospitals and Clinics, Ambulatory Centers, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Peripheral Neuropathy Market by Type
6.1.2: Growth Opportunities for the Global Peripheral Neuropathy Market by Treatment
6.1.3: Growth Opportunities for the Global Peripheral Neuropathy Market by End Use
6.1.4: Growth Opportunities for the Global Peripheral Neuropathy Market by Region
6.2: Emerging Trends in the Global Peripheral Neuropathy Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Peripheral Neuropathy Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Peripheral Neuropathy Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbott
7.2: Bristol Myers Squibb
7.3: Novartis
7.4: Eli Lilly
7.5: Pfizer
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Peripheral Neuropathy Market Report.